Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
GE HealthCare Technologies Inc has a consensus price target of $92.29 based on the ratings of 19 analysts. The high is $110 issued by Argus Research on April 1, 2024. The low is $73 issued by UBS on May 5, 2025. The 3 most-recent analyst ratings were released by Morgan Stanley, UBS, and Goldman Sachs on May 6, 2025, May 5, 2025, and May 1, 2025, respectively. With an average price target of $77.67 between Morgan Stanley, UBS, and Goldman Sachs, there's an implied 8.68% upside for GE HealthCare Technologies Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/06/2025 | Buy Now | 9.14% | Morgan Stanley | Patrick Wood50% | $86 → $78 | Maintains | Equal-Weight | Get Alert |
05/05/2025 | Buy Now | 2.15% | UBS | Graham Doyle42% | $74 → $73 | Upgrade | Sell → Neutral | Get Alert |
05/01/2025 | Buy Now | 14.74% | Goldman Sachs | David Roman39% | $94 → $82 | Maintains | Buy | Get Alert |
05/01/2025 | Buy Now | 24.54% | Wells Fargo | Larry Biegelsen65% | $103 → $89 | Maintains | Overweight | Get Alert |
05/01/2025 | Buy Now | 18.94% | Evercore ISI Group | Vijay Kumar50% | $96 → $85 | Maintains | Outperform | Get Alert |
04/30/2025 | Buy Now | 20.34% | Citigroup | Joanne Wuensch74% | $105 → $86 | Maintains | Buy | Get Alert |
04/23/2025 | Buy Now | 23.14% | Piper Sandler | — | $104 → $88 | Maintains | Overweight | Get Alert |
03/11/2025 | Buy Now | 39.93% | Goldman Sachs | David Roman39% | $85 → $100 | Upgrade | Neutral → Buy | Get Alert |
02/14/2025 | Buy Now | 44.13% | Wells Fargo | Larry Biegelsen65% | $96 → $103 | Maintains | Overweight | Get Alert |
02/13/2025 | Buy Now | 53.92% | Citigroup | Joanne Wuensch74% | $103 → $110 | Maintains | Buy | Get Alert |
01/08/2025 | Buy Now | 44.13% | Jefferies | Matthew Taylor70% | $95 → $103 | Upgrade | Hold → Buy | Get Alert |
10/31/2024 | Buy Now | 34.33% | Wells Fargo | Larry Biegelsen65% | $95 → $96 | Maintains | Overweight | Get Alert |
10/01/2024 | Buy Now | 42.73% | Evercore ISI Group | Vijay Kumar50% | $98 → $102 | Maintains | Outperform | Get Alert |
09/30/2024 | Buy Now | 42.73% | Stifel | Rick Wise73% | $100 → $102 | Maintains | Buy | Get Alert |
09/26/2024 | Buy Now | 3.55% | UBS | Graham Doyle42% | $84 → $74 | Downgrade | Neutral → Sell | Get Alert |
09/18/2024 | Buy Now | 39.93% | BTIG | Ryan Zimmerman70% | → $100 | Upgrade | Neutral → Buy | Get Alert |
09/09/2024 | Buy Now | 25.94% | JP Morgan | Robbie Marcus65% | → $90 | Initiates | → Neutral | Get Alert |
08/06/2024 | Buy Now | 39.93% | Stifel | Rick Wise73% | → $100 | Initiates | → Buy | Get Alert |
07/02/2024 | Buy Now | 17.54% | UBS | Graham Doyle42% | $88 → $84 | Maintains | Neutral | Get Alert |
05/30/2024 | Buy Now | 21.74% | Goldman Sachs | David Roman39% | → $87 | Initiates | → Neutral | Get Alert |
05/01/2024 | Buy Now | 20.34% | B of A Securities | Craig Bijou77% | $94 → $86 | Maintains | Neutral | Get Alert |
05/01/2024 | Buy Now | 46.93% | Mizuho | Anthony Petrone64% | $110 → $105 | Maintains | Buy | Get Alert |
04/11/2024 | Buy Now | 53.92% | Mizuho | Anthony Petrone64% | $96 → $110 | Maintains | Buy | Get Alert |
04/04/2024 | Buy Now | 39.93% | Evercore ISI Group | Vijay Kumar50% | $93 → $100 | Maintains | Outperform | Get Alert |
04/03/2024 | Buy Now | 44.13% | Citigroup | Joanne Wuensch74% | $88 → $103 | Maintains | Buy | Get Alert |
04/01/2024 | Buy Now | 53.92% | Argus Research | David Toung68% | $80 → $110 | Maintains | Buy | Get Alert |
02/15/2024 | Buy Now | 39.93% | HSBC | Sezgi Oezener33% | → $100 | Initiates | → Buy | Get Alert |
02/12/2024 | Buy Now | 20.34% | Morgan Stanley | Patrick Wood50% | $74 → $86 | Maintains | Equal-Weight | Get Alert |
02/12/2024 | Buy Now | 23.14% | UBS | Graham Doyle42% | $66 → $88 | Upgrade | Sell → Neutral | Get Alert |
02/07/2024 | Buy Now | 34.33% | Mizuho | Anthony Petrone64% | $94 → $96 | Maintains | Buy | Get Alert |
12/04/2023 | Buy Now | 3.55% | Morgan Stanley | Patrick Wood50% | $78 → $74 | Maintains | Equal-Weight | Get Alert |
11/30/2023 | Buy Now | 11.94% | Jefferies | Matthew Taylor70% | → $80 | Initiates | → Hold | Get Alert |
11/27/2023 | Buy Now | -7.65% | UBS | Graham Doyle42% | $86 → $66 | Downgrade | Neutral → Sell | Get Alert |
09/19/2023 | Buy Now | 14.74% | Citigroup | Joanne Wuensch74% | → $82 | Initiates | → Buy | Get Alert |
08/16/2023 | Buy Now | 25.94% | Wells Fargo | Larry Biegelsen65% | → $90 | Initiates | → Overweight | Get Alert |
07/31/2023 | Buy Now | 14.74% | B of A Securities | Craig Bijou77% | → $82 | Initiates | → Neutral | Get Alert |
07/26/2023 | Buy Now | 9.14% | Morgan Stanley | Patrick Wood50% | $76 → $78 | Maintains | Equal-Weight | Get Alert |
06/28/2023 | Buy Now | 6.35% | Morgan Stanley | Patrick Wood50% | → $76 | Initiates | → Equal-Weight | Get Alert |
06/27/2023 | Buy Now | 6.35% | Morgan Stanley | Patrick Wood50% | → $76 | Initiates | → Equal-Weight | Get Alert |
05/16/2023 | Buy Now | 35.73% | Oppenheimer | Suraj Kalia59% | → $97 | Initiates | → Outperform | Get Alert |
04/26/2023 | Buy Now | 31.53% | Mizuho | Anthony Petrone64% | $92 → $94 | Maintains | Buy | Get Alert |
04/26/2023 | Buy Now | 20.34% | UBS | Graham Doyle42% | → $86 | Initiates | → Neutral | Get Alert |
04/19/2023 | Buy Now | 32.93% | Piper Sandler | Jason Bednar52% | → $95 | Initiates | → Overweight | Get Alert |
04/18/2023 | Buy Now | 28.73% | Mizuho | Anthony Petrone64% | $90 → $92 | Maintains | Buy | Get Alert |
04/10/2023 | Buy Now | — | BTIG | Ryan Zimmerman70% | — | Initiates | → Neutral | Get Alert |
03/13/2023 | Buy Now | 25.94% | Evercore ISI Group | Vijay Kumar50% | → $90 | Initiates | → Outperform | Get Alert |
02/17/2023 | Buy Now | 25.94% | Mizuho | Anthony Petrone64% | → $90 | Initiates | → Buy | Get Alert |
01/19/2023 | Buy Now | — | Redburn Partners | Ed Ridley-Day66% | — | Initiates | → Buy | Get Alert |
01/04/2023 | Buy Now | — | Edward Jones | John Boylan73% | — | Initiates | → Hold | Get Alert |
The latest price target for GE HealthCare Techs (NASDAQ:GEHC) was reported by Morgan Stanley on May 6, 2025. The analyst firm set a price target for $78.00 expecting GEHC to rise to within 12 months (a possible 9.14% upside). 19 analyst firms have reported ratings in the last year.
The latest analyst rating for GE HealthCare Techs (NASDAQ:GEHC) was provided by Morgan Stanley, and GE HealthCare Techs maintained their equal-weight rating.
The last upgrade for GE HealthCare Technologies Inc happened on May 5, 2025 when UBS raised their price target to $73. UBS previously had a sell for GE HealthCare Technologies Inc.
The last downgrade for GE HealthCare Technologies Inc happened on September 26, 2024 when UBS changed their price target from $84 to $74 for GE HealthCare Technologies Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GE HealthCare Techs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GE HealthCare Techs was filed on May 6, 2025 so you should expect the next rating to be made available sometime around May 6, 2026.
While ratings are subjective and will change, the latest GE HealthCare Techs (GEHC) rating was a maintained with a price target of $86.00 to $78.00. The current price GE HealthCare Techs (GEHC) is trading at is $71.47, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.